According to Mehr corresponde, Dr. Sharif Moradi at the 26th Congress and the 24th Iernational Festival of Royan, held on Saturday, September 5, at the Royan Research Institute, said: “The world’s approach of stem cell knowledge is in the world and in Royan to treat curre medical knowledge.” That is, in some diseases of the curre modern medical treatme, traditional methods are still considered. For example, myocardial infarction is not easily treated with curre methods, and in the world and Iran, myocardial infarction is a first -rate killer. Also, liver disorders and other diseases that modern medicine still have no definitive cure for our activities in the field of stem cell knowledge.
He coinued: “For this purpose, we have invited four foreign and iernational speakers at this congress of stem cells to prese their scieific findings with the scieific community.” We have set up two axes in Congress, seven of which are purely scieific; The professors in these axes prese their new and importa findings. The other three are accessories and vital accessories to get knowledge.
From fetal and stem cells to cell therapy and tissue engineering
The 21st Iernational Congress of Biology and Technology of Royan Stem Cell Technology explained about the axes of the congress: The first axis is the fetus and stem cells and examines what these cells are capable and how they can produce all human cells. The second axis is molecular biomedical that provides better treatme by understanding the molecular of the cell and body and diseases. The third axis is biological engineering and tissue engineering, meaning that if the damaged tissue can be engineered, many anomalies and diseases will be treated. The fourth axis is cell therapy and therapeutic molecule in which the embryo performs clinical trials based on stem cells.
Using infertile couple stem cells to create future fetus
“For some future needs, we use the stem cells of infertile couples and emphasize that we use the same couples’ stem cells,” he said. These cells are transformed io laboratory embryos derived from the same couple, and this path moves to significa improvemes. This is one of the axes that are actually deals with laboratory organisms and embryos and disease modeling.
Applications of Artificial Ielligence in Stem Cells and Cancer
One of the axes is the use of artificial ielligence in the field of stem cells and cancer. After a heart disease, the second -rate killer is, and its social and family consequences are even greater than the heart attack; Because myocardial infarction quickly determines the task, the cancer can have long consequences.
He added: The remaining three axes are the side axes but vital. The first axis is regulatory and standardization regulations; That is, if you wa to convert a laboratory product or stem cell io a laboratory achieveme, it should be examined whether this achieveme can be repeated. The second axis is to meet the secretaries of scieific journals. One of our main discussions is the ieraction of researchers, research faculty and studes with iernational scieific journals. The third axis is to meet with erepreneurs; To this end, we have invited some of the top executives of the top companies in the field of pharmaceutical, cell therapy and remedial medicine to share their valuable experiences with the scieific community.
The congress’s scieific secretary noted: The purpose of this congress is to share fundameal knowledge and cell therapy with the scieific community by inviting promine national and iernational scholars. The congress has a retraining privilege and will be useful for participas in the fields of adult blood and cancer, a doctor of medical engineering, tissue engineering, molecular genetic medicine, a doctor of biotechnology and medical cellular sciences.
Details of the 20th Seminar of Nursing and Midwifery
“We believe that having a healthy community depends on having a healthy and conscious treatme staff, which includes doctors and nurses,” said Dr. Zahra Ezzabadi. Given this mission, we are trying to prese the latest scieific achievemes in the field of infertility to colleagues in this congress and seminar so that we can have a partial role in the scieific and practical promotion of this field.
He added: “This year we are hosting colleagues on Wednesday and Thursday, 12th and 13th of September. This seminar consists of four sections. In the first part, the issue of infertility is raised and we have a review of new achievemes in this area. First, we start with the discussion of skeleton and new treatme in paties with endometriosis, and topics on the manageme and preveion of bacterial and viral infectious diseases and their impact on infertility treatme results are discussed.
He noted: In the second part, given the ery of artificial ielligence in the treatme of infertility, a special section is dedicated to artificial ielligence. First, the use of artificial ielligence in diagnosis and treatme, predicts the success rate of treatme, and patie -ceered, and ultimately, the poteial challenges and restrictions on the use of artificial ielligence will be explored.
Ezzabadi said the other part is dedicated to sexual health and fertility. First, the illnesses and psychological issues affecting sexual health and then the effect of environmeal pollutas will be examined. Finally, with the nursing and midwifery approach, there are strategies to promote sexual health.
“The last panel is dedicated to genetic issues and the genetic problems of men and women and their impact on fertility will be investigated,” she said. The role of genetic counseling in diagnosis and treatme and fetal health promotion methods is also discussed. This seminar has a retraining rating for nurses, midwives and paramedics.
(tagstotranslate) Tissue Engineering (T) Royan Research Institute (T) Infertility (T) Congress of the Royan Congress
